165 related articles for article (PubMed ID: 22250039)
1. Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.
Stewart DR; Pemov A; Van Loo P; Beert E; Brems H; Sciot R; Claes K; Pak E; Dutra A; Lee CC; Legius E
Genes Chromosomes Cancer; 2012 May; 51(5):429-37. PubMed ID: 22250039
[TBL] [Abstract][Full Text] [Related]
2. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C
Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704
[TBL] [Abstract][Full Text] [Related]
3. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association.
Brems H; Park C; Maertens O; Pemov A; Messiaen L; Upadhyaya M; Claes K; Beert E; Peeters K; Mautner V; Sloan JL; Yao L; Lee CC; Sciot R; De Smet L; Legius E; Stewart DR
Cancer Res; 2009 Sep; 69(18):7393-401. PubMed ID: 19738042
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
[TBL] [Abstract][Full Text] [Related]
5. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
[TBL] [Abstract][Full Text] [Related]
6. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
[TBL] [Abstract][Full Text] [Related]
7. Glomus tumors in individuals with neurofibromatosis type 1.
Kumar MG; Emnett RJ; Bayliss SJ; Gutmann DH
J Am Acad Dermatol; 2014 Jul; 71(1):44-8. PubMed ID: 24685357
[TBL] [Abstract][Full Text] [Related]
8. Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1.
Steinemann D; Arning L; Praulich I; Stuhrmann M; Hasle H; Stary J; Schlegelberger B; Niemeyer CM; Flotho C
Haematologica; 2010 Feb; 95(2):320-3. PubMed ID: 20015894
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
10. Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions.
Roehl AC; Vogt J; Mussotter T; Zickler AN; Spöti H; Högel J; Chuzhanova NA; Wimmer K; Kluwe L; Mautner VF; Cooper DN; Kehrer-Sawatzki H
Hum Mutat; 2010 Oct; 31(10):1163-73. PubMed ID: 20725927
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1.
Noë M; Pea A; Luchini C; Felsenstein M; Barbi S; Bhaijee F; Yonescu R; Ning Y; Adsay NV; Zamboni G; Lawlor RT; Scarpa A; Offerhaus GJA; Brosens LAA; Hruban RH; Roberts NJ; Wood LD
Mod Pathol; 2018 Oct; 31(10):1532-1538. PubMed ID: 29849115
[TBL] [Abstract][Full Text] [Related]
12. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
[TBL] [Abstract][Full Text] [Related]
13. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis.
Glover TW; Stein CK; Legius E; Andersen LB; Brereton A; Johnson S
Genes Chromosomes Cancer; 1991 Jan; 3(1):62-70. PubMed ID: 1906341
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1.
Stewart DR; Sloan JL; Yao L; Mannes AJ; Moshyedi A; Lee CC; Sciot R; De Smet L; Mautner VF; Legius E
J Med Genet; 2010 Aug; 47(8):525-32. PubMed ID: 20530151
[TBL] [Abstract][Full Text] [Related]
15. Congenital disseminated neurofibromatosis type 1: a clinical and molecular case report.
Stewart H; Bowker C; Edees S; Smalley S; Crocker M; Mechan D; Forrester N; Spurlock G; Upadhyaya M
Am J Med Genet A; 2008 Jun; 146A(11):1444-52. PubMed ID: 18438896
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
[TBL] [Abstract][Full Text] [Related]
17. Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1.
Courtney E; Chan SH; Li ST; Ishak D; Merchant K; Shaw T; Chay WY; Chin FHX; Wong WL; Wong A; Ngeow J
Fam Cancer; 2020 Oct; 19(4):353-358. PubMed ID: 32405727
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity on chromosome arm 17p in small cell lung carcinomas, but not in neurofibromas, in a patient with von Recklinghausen neurofibromatosis.
Shimizu E; Shinohara T; Mori N; Yokota J; Tani K; Izumi K; Obashi A; Ogura T
Cancer; 1993 Feb; 71(3):725-8. PubMed ID: 8094318
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17.
Skuse GR; Kosciolek BA; Rowley PT
Genes Chromosomes Cancer; 1989 Sep; 1(1):36-41. PubMed ID: 2577271
[TBL] [Abstract][Full Text] [Related]
20. 17q inversion involving the neurofibromatosis type one locus in a family with neurofibromatosis type one.
Asamoah A; North K; Doran S; Wagstaff J; Ogle R; Collins FS; Korf BR
Am J Med Genet; 1995 Aug; 60(4):312-6. PubMed ID: 7485267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
